In front of an audience of companies and organisations whose mission is to help realise the further development and growth of the Dutch life sciences industry, the winner of the Venture Challenge was announced. On the stage of the Dutch Life Sciences Conference, BIMINI Biotech became the proud winner of this year’s fall edition. The innovative spin-off from the University Medical Center Utrecht aims to target the growth hormone receptor for the treatment of cancer.
MSD, het grootste geneesmiddelenbedrijf in Nederland, verdubbelt de komende jaren haar capaciteit voor biotechproductie in Oss. Met de vergroting van de capaciteit en de nieuwe faciliteiten kan MSD vanuit Oss geneesmiddelen leveren aan de rest van de wereld.
Met steun van de Hartstichting is een groot hartonderzoek gestart. Het doel is om harten volledig en blijvend te genezen. Wetenschappers onderzoeken hoe ze een hart kunnen herstellen buiten het lichaam van de patiënt.
Last month, the first edition of the Health Impact Accelerator (HIA) started. In just ten weeks, the participants are prepared to become social entrepreneurs. During the HIA they are introduced to the added value - and the challenges - of social entrepreneurship. Moreover, they translate their idea into a solid business case.
The Health~Holland Newsflash of November 2019 is out now. Read our newsletter that brings you the latest developments in the Top Sector Life Sciences & Health and get insight in the remarkable progress that is taking place in the Dutch Life Sciences & Health sector.
Worldwide there are 37 million people living with HIV. Although we believe that finding a cure is possible in the near future, we cannot do this alone. Therefore, Aidsfonds and Top Sector Life Sciences & Health (Health~Holland) have decided to partner up and call on you to help us find the cure. We believe that together we can reach an HIV cure!
On 15 November the Netherlands officially delivered the new headquarters for the European Medicines Agency (EMA). Minister Bruno Bruins (Medical Care and Sport) complimented everyone involved with this special achievement. The building is situated in the Amsterdam Zuidas.
Researchers at Dutch universities can spend the coming years working with industry to realise new steps in the fight against cancer. Eight research groups have received funding so that scientists and companies can work together on technical innovations for the prevention, diagnosis and better treatment of cancer. Top Sector Life Sciences & Health, NWO and the Dutch Cancer Society have invested 5.4 million euros in the projects; the companies and organisations involved are contributing more than 1.5 million euros.
Have you developed an innovative healthcare product? And do you want to expand your market or further improve the product? Then register for the fifth edition of the National Health Care Innovation Award and have a chance to win € 15,000.
On 11 December a matchmaking meeting will take place for a new international public-private consortium to stop type 2 diabetes: Netherlands-Canada Diabetes Type 2 Research consortium Is your company interested in this? Then register now to jointly find a solution for type 2 diabetes!